AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2015
Jan 5, 2015
34931_dirs_2015-01-05_0f3781b3-a759-44c1-acdc-5a0a1001db41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2015-01-05
Reporting Person: VATERS ROBERT S (President & CFO)
More from LISATA THERAPEUTICS, INC.
Merger & Acquisition
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3